Engineering a Novel Bivalent Oral Vaccine against Enteric Fever

Engineering a Novel Bivalent Oral Vaccine against Enteric Fever

Enteric fever is a major global healthcare issue caused largely by <i>Salmonella enterica</i> serovars Typhi and Paratyphi A. The objective of this study was to develop a novel, bivalent oral vaccine capable of protecting against both serovars. Our approach centred on genetically enginee...

Full description

Bibliographic Details
Main Authors: Annelise Soulier, Claudia Prevosto, Mary Chol, Livija Deban, Rocky M. Cranenburgh
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:International Journal of Molecular Sciences
Subjects:
bacteria
salmonella
Typhi
Paratyphi A
enteric fever
vaccine
Online Access:https://www.mdpi.com/1422-0067/22/6/3287

Internet

https://www.mdpi.com/1422-0067/22/6/3287

Similar Items